All News
Filter News
Found 808,987 articles
-
SeaSpine Reports Third Quarter 2021 Financial ResultsProvides Financial Outlook for Fourth Quarter 2021
10/28/2021
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended September 30, 2021.
-
Awakn Life Sciences Identifies New Chemical Series via Its Drug Discovery Program
10/28/2021
This further defines development pathways for next generation of psychedelic medicines to treat addiction.
-
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to Lack of Quorum
10/28/2021
CytoDyn Inc. today convened and then adjourned the 2021 Annual Meeting of Shareholders (the “Annual Meeting”) without transacting any other business. The Annual Meeting was adjourned to be held virtually on Wednesday, November 24, 2021 at 8:00 a.m. Pacific Time.
-
Evofem Biosciences to Report Third Quarter 2021 Results and Provide Corporate Update on Monday, November 15, 2021
10/28/2021
Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the third quarter ended September 30, 2021 on Monday, November 15, 2021 at 4:30 p.m. ET ( 1:30 p.m. PT ).
-
PolarityTE to Report Third Quarter Financial Results on November 10, 2021
10/28/2021
PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the quarter ended September 30, 2021 by press release on Wednesday, November 10, 2021 at approximately 7:00 a.m. Eastern Time .
-
Amyris to Host Third Quarter 2021 Financial Results Conference Call on November 8
10/28/2021
Amyris, Inc. today announced that it will issue its financial results for the third quarter ended September 30, 2021 after the close of the financial markets on Monday, November 8, 2021.
-
Ocular Therapeutix™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting
10/28/2021
Ocular Therapeutix ™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting
-
Fulcrum Therapeutics™ to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Thursday, November 4, 2021 at 8:00 a.m. ET
10/28/2021
Fulcrum Therapeutics, Inc. today announced that its third quarter 2021 financial results will be released on Thursday, November 4, 2021 before the U.S. financial markets open.
-
Clearside Biomedical to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Wednesday, November 10, 2021
10/28/2021
Clearside Biomedical, Inc. announced today that its third quarter 2021 financial results will be reported on Wednesday, November 10, 2021 after the close of the financial markets.
-
OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time
10/28/2021
OpGen, Inc. announced today that the Company will provide a business update and report its third quarter 2021 financial results after the close of the U.S. financial markets on Thursday, November 11, 2021.
-
Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2021 Earnings and Company Updates
10/28/2021
Intellia Therapeutics, Inc. will present its third quarter 2021 financial results and operational highlights in a conference call on November 4, 2021 at 8 a.m. ET.
-
Kura Oncology to Report Third Quarter 2021 Financial Results
10/28/2021
Kura Oncology, Inc. today announced that it will report third quarter 2021 financial results after the close of U.S. financial markets on Thursday, November 4, 2021.
-
Alimera Sciences Announces Third Quarter 2021 Financial Results
10/28/2021
Alimera Sciences, Inc. today announced financial results for the third quarter of 2021. Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results.
-
Oyster Point Pharma to Report Third Quarter 2021 Financial Results on November 4, 2021Conference Call and Webcast Scheduled for November 4, 2021, 4:30 p.m. Eastern Time
10/28/2021
Oyster Point Pharma, Inc. today announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021, after the market close.
-
Diffusion Pharmaceuticals to Participate in the Alliance Global Partners Biotech & Specialty Pharma Conference
10/28/2021
Diffusion Pharmaceuticals Inc. will participate in the 2021 Alliance Global Partners Biotech & Specialty Pharma Conference taking place November 10, 2021.
-
Provention Bio to Report Third Quarter 2021 Financial Results on November 4, 2021
10/28/2021
Provention Bio, Inc. today announced that it will report its third quarter 2021 financial results on Thursday, November 4, 2021 , before the opening of the U.S. financial markets.
-
Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021
10/28/2021
Aerie Pharmaceuticals, Inc. announced today that its third quarter 2021 financial results will be released after the market closes on Thursday, November 4, 2021.
-
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
10/28/2021
Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET.
-
Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021
10/28/2021
Baudax Bio, Inc. today announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021.
-
Chimerix to Report Third Quarter 2021 Financial Results and Provide an Operational Update on November 4, 2021
10/28/2021
Chimerix today announced that it will host a live conference call and audio webcast on Thursday, November 4, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021, and to provide an operational update.